VJHemOnc is committed to improving our service to you

iwCLL 2019 | Utilizing the NOTCH1 pathway in CLL treatment

VJHemOnc is committed to improving our service to you

Silvia Deaglio

Silvia Deaglio, MD, PhD, University of Turin, Turin, Italy, describes the mechanisms by which NOTCH1 mutations can cause chronic lymphocytic leukemia (CLL) and the how we can target treatment with this knowledge. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter